ABSTRACT Cryptococcus neoformans is a human opportunistic fungal pathogen causing severe disseminated meningoencephalitis, mostly in patients with cellular immune defects. This species is divided into three serotypes: A, D, and the AD hybrid. Our objectives were to compare population structures of serotype A and D clinical isolates and to assess whether infections with AD hybrids differ from infections with the other serotypes. For this purpose, we analyzed 483 isolates and the corresponding clinical data from 234 patients enrolled during the CryptoA/D study or the nationwide survey on cryptococcosis in France. Isolates were characterized in terms of ploidy, serotype, mating type, and genotype, utilizing flow cytometry, serotype-and mating typespecific PCR amplifications, and multilocus sequence typing (MLST) methods. Our results suggest that C. neoformans serotypes A and D have different routes of multiplication (primarily clonal expansion versus recombination events for serotype A and serotype D, respectively) and important genomic differences. Cryptococcosis includes a high proportion of proven or probable infections (21.5%) due to a mixture of genotypes, serotypes, and/or ploidies. Multivariate analysis showed that parameters independently associated with failure to achieve cerebrospinal fluid (CSF) sterilization by week 2 were a high serum antigen titer, the lack of flucytosine during induction therapy, and the occurrence of mixed infection, while infections caused by AD hybrids were more likely to be associated with CSF sterilization. Our study provides additional evidence for the possible speciation of C. neoformans var. neoformans and grubii and highlights the importance of careful characterization of causative isolates. 
mainly for serotype A using PCR fingerprinting, multilocus sequence typing (MLST), or variable-number tandem repeat (VNTR) methods (7, 17, (19) (20) (21) (22) (23) (24) . The majority of serotype A isolates exhibit clonal expansion with very few recombination events and low genetic diversity (2) . These results show mitotic clonal expansion, inbreeding via unisexual reproduction of clonally related or identical isolates, or both. Geographic specificity has been observed so far only for isolates recovered in Botswana that exhibit higher genetic diversity and recombination events (25) and for environmental isolates in India that show evidence of recombination and extensive gene flow (26) . The experimental design (sampling and geographical area) may contribute to differences in the extent of clonal expansion versus recombination events reported (6) . For serotype D, a unique molecular type is usually described as VNIV or AFLP2 (27) (28) (29) (30) . Evidence of recombination was found after analysis of 58 environmental isolates from North Carolina (31) and 33 from other areas (11) , which differs from results obtained with Dutch isolates (17) .
In humans, serotype A is the more frequent serotype and is thought to be associated with more severe infections, at least in HIV-infected patients (5) . In experimental animal models, most studies have established higher virulence for serotype A than serotype D and for MAT␣ than MATa (32, 33) . Contradictory results have been published on AD hybrids. Their virulence may vary depending on the inoculation route and also on the chromosomal composition, with higher virulence for strains containing a majority of the serotype A genome (12, 34, 35) . Overall, there are few clinical data on patients infected with AD hybrids.
Our objectives were thus to (i) analyze the population structure of serotype A versus serotype D using isolates recovered from patients diagnosed with cryptococcosis in France and (ii) analyze clinical presentations and outcomes in patients infected with AD hybrids compared to serotype A or D.
RESULTS

Molecular characterization of clinical isolates. Among the 400
CryptoA/D isolates recovered from the 181 patients, 61% (244) corresponded to serotype A, 19% (76) to serotype D, and 20% (80) to AD hybrids. Of note, the serotypes determined here by PCR matched those obtained previously using fluorescence microscopy (5) except for patients infected with AD hybrids that were previously considered infected with either serotype A (20/ 131, 15%) or D (11/50, 22%) . Overall, diploid strains were found in 52 (29%) patients (37 hybrids, 6 serotype A, and 9 serotype D). None of the serotype A isolates were MATa, whereas 13% (13/97) of the serotype D isolates were MATa. Among the 37 (20%) patients infected with AD hybrids, 25 (67%) were infected with ␣ADa, 3 (8%) with ␣AD␣, and 6 (16%) with aAD␣. For three hybrids, only one allele of the mating types was identified (1 of each aAD-, -ADa, and -AD␣), probably due to partial or complete chromosome loss.
Among the 181 CryptoA/D patients, 26 (14.4%) had proven mixed infection with mixed serotypes (12 patients), ploidies (6), genotypes (2) , or a combination of mixed serotypes/genotypes (2) or serotypes/ploidies (4) ( Table 1) , confirming data obtained for a subset of the patients (36) . Patients with mixed genotypes of serotype A were infected with unrelated (patient 27) or related (patient 197) isolates. Patients with mixed ploidies were infected with haploid and diploid isolates sharing the same genetic profile, suggesting in vivo diploidization by endoreplication (36) . Some patients were infected with unrelated A (or D) and AD isolates (differences in Ն3/5 loci), suggesting coinoculation. Finally, one patient was infected with potentially related D and AD isolates (differing at only 1 of 5 loci), suggesting possible in vivo hybridization even though the serotype A partner was never uncovered (36) (see Table S1 in the supplemental material). Mixed infections were suspected for 13 additional patients (PCR on the original haploid isolate suggested a mixture of A and D or the presence of AD, but the 10 single colonies analyzed for each patient were haploid and either A [9/13] or D [4/13] (Fig. 1) . The genetic diversity was greater for serotype D than for serotype A, according to maximumparsimony phylogenetic analysis (Fig. 2) , gene diversity, and average number of alleles per locus (Table 2) .
For both populations, the observed variance was significantly different from the expected variance (P Ͻ 0.0001), suggesting linkage disequilibrium among the 7 loci. Similarly, a significant test of congruence for 10/21 combinations for serotype D and 8/21 for serotype A suggested that some loci exhibited coevolution confirming linkage disequilibrium. However, based on the allelic compatibility test, compatibility was observed in 19/21 graphs for serotype D and in 6/21 graphs for serotype A ( Fig. 3 ; also, see Fig. S1 in the supplemental material) serving as evidence of recombination in both but more recombination events among serotype D than serotype A populations. Furthermore, the index of association (I A ) was not significantly different from zero, suggesting that some recombination events could occur in the serotype D population, which contrasted with results obtained for serotype A. Recombination parameters (S, R, and Rm) differed between serotypes D and A (Table 2) . Altogether, these results suggested recombination events in the serotype D and clonal expansion for the serotype A populations.
Finally, multiple alignment of the concatenated sequences of the 7 loci (Ͼ4,000 bp in length) showed that similarity ranged from 98.7% to 100% among serotype A isolates and from 99.2% to 100% among serotype D isolates. In contrast, 81 to 92% similarity was observed between sequences of A and D isolates. Multiple alignments revealed 7 gap positions corresponding to 20 (range, 1-7) bp for serotype A isolates, and 22 gap positions corresponding to 81 (range, 1-19) bp for serotype D isolates. These indels were distributed among all isolates and localized mainly in the IGS1 locus (5/7 positions for serotype A and 18/22 positions for serotype D), which is an untranslated region.
Influence of AD hybrids on clinical presentation and outcome of cryptococcosis. We compared the characteristics of the patients depending on the infecting serotype (A, D, and AD) for the 155 patients infected with a unique strain (Tables 3 and 4) . Overall, the three populations did not differ in terms of sex or age. The proportion of patients infected with AD hybrids did not differ according to the continent of birth, whereas there were no serotype D isolates in patients born in Africa. Of note, no association between geographical origin and cluster or ST was observed for serotype A or D isolates. There was a trend toward fewer serotype D and more AD hybrids among HIV-infected patients, whereas it was the opposite among HIV-negative patients. When four risk categories among the 33 HIV-negative patients ("malignancy," "solid organ transplantation," "others" [disease/treatment], and "none" [no known risk factor]) were considered, "malignancy" and "others" were the major risk factors for the 19 patients infected with A, "malignancy" and "none" were the major risk factors for the 10 infected with D, and all four categories were recorded for the 4 patients infected with AD. Clinical presentation and disease severity were similar despite a trend toward less disseminated infection and less frequent abnormal lung imaging with AD hybrids, lower serum antigen titers with serotype D and AD hybrids, and less frequent abnormal brain imaging with serotype D. Intracranial pressure was recorded for only 21 patients and was increased in 16 (14 infected with serotype A, 1 with D, and 1 with AD). Induction therapy with a combination of amphotericin B and flucytosine was prescribed with similar frequencies to patients infected with serotypes A and AD and significantly less frequently to patients infected with serotype D. Fluconazole induction therapy mirrored that of the amphotericin B-flucytosine combination. The proportion of mycological failure (nonsterilization at week 2 despite antifungal therapy) was lower in the case of the AD hybrid than in that of serotype A or D. This was significant when patients with meningoencephalitis were considered and near significant when all cases (meningeal and nonmeningeal cryptococcosis) were considered. In a multivariate analysis on the entire database (unique and mixed infections), parameters independently associated with mycological failure (based on cerebrospinal fluid [CSF] sterilization) were a high serum antigen titer, lack of flucytosine during induction therapy, and mixed infection, while infection with AD hybrids was more often associated with mycological cure (Table 4) . Overall survival at 3 months was not different in patients infected by hybrids compared to the others. Ten patients (1 with AD hybrids and 9 with serotype A) had neurological sequelae.
DISCUSSION
We used clinical data and isolates collected during the nationwide surveillance on cryptococcosis and the CryptoA/D study to further analyze Cryptococcus biology and the disease it causes. Parts of the data sets have been used in other studies (5, 36, 37) . However, the discovery of AD hybrid isolates among those previously classified as serotype A or D allowed us to analyze here how the disease caused by AD hybrids in humans differed from that caused by A or D (5) . Likewise, expanding our search for mixed infections to the entire data set of the CryptoA/D study allowed us to confirm the high incidence of mixed infections during cryptococcosis but also to include it with the data for AD hybrids in the model of multivariate analysis studying the parameters influencing outcome of infection. We thus confirmed previous findings but also extended our understanding of the biology of an important fungal pathogen and of parameters potentially useful for the management of cryptococcosis.
The diversity of the French C. neoformans clinical isolates was higher than previously reported (5), with a proportion of AD hybrids (20%) and a distribution of mating type profiles similar to European data (9) . Cogliati et al. and Li et al. found that 71% of AD hybrids harbored the MATa allele (73% here), suggesting that AD hybrids could be a reservoir preserving the MATa mating type, rarely found outside Africa for serotype A (9, 11) . The hypothetical African origin of AD hybrids (7) was further supported by the similar proportion of AD hybrids among patients born in Africa and in other continents in our study.
The difference in the population structures of serotypes A and D was striking. Serotype A is considered more virulent than serotype D, and its clonal expansion (at least for MAT␣) could con- a Mixed infection that was described in our previous study (36) .
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tribute to maintain genomic markers associated with virulence. Our data (low genetic diversity, lack of MATa, linkage disequilibrium, values of recombination parameters, and low allelic compatibility) confirmed the hypothesis of clonal expansion for serotype A in France. The presence of both mating types can facilitate recombination in a population, and high genetic diversity within a population is often associated with sexual reproduction (11, 38) . It is known that sexual reproduction of serotype D is robust and not strain specific (39) , whereas 50% of clinical and environmental isolates of serotype A are fertile (40) . Despite linkage disequi- ject of debate for many years (3, 6) . Known differences between the two serotypes include geographical distribution (41), hostrelated susceptibility and type of disease produced (5), skin tropism (41), maximal growth temperature (42), proportion of MATa (16), monokaryotic fruiting for MATa (43) , and overall genome differences (85 to 90% nucleotide sequence identity between JEC21 and H99 genomes [44, 45] ). Here, we found major differences in population structure and 8 to 19% nucleotide difference over 4,000 bp. Reproductive isolation has been considered the main mechanism of speciation (46) . Even if serotype A di- No. of graphs with allelic compatibility/total ( Fig. 3 and Fig. S1 (9, 44) . AD hybrids seem to be locked in the diploid state because of genomic differences preventing progression through meiosis. Furthermore, basidiospores generated from intervarietal matings have a low viability and low propensity to germinate (39) . On the basis of reproductive isolation already described and phylogenetic distance confirmed by our results, both varieties could be classified into different species (6, 47) . In their new study, Hagen et al. (3) propose recognition of both varieties of C. neoformans as new species (C. neoformans for serotype A and the newly proposed Cryptococcus deneoformans for serotype D). This is based on the phylogenetic analysis of 11 genetic loci and on biochemical, physiological, and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry profiles. Our results are thus in agreement with this new taxonomic classification (3) . A fascinating discovery of the systematic screening of original isolates was the high proportion of mixed infections (21.5%), confirming and extending with 181 patients the results obtained with 49 (36) . As reported, these mixed infection were the results of either coinoculation or in vivo evolution (transitions in ploidy or microevolution). However, we did not uncover hybridization that could explain the simultaneous presence of A, D, and AD hybrids in the same patient. It was important to expand the sample size to the entire population of the CryptoA/D study to ensure that our original finding was not due to some selection bias. This study also allowed us to determine by univariate analysis that patients infected with AD hybrids differed from those infected with serotype A or D (Table 4) , especially in terms of type of infection (less frequent dissemination based on culture and serum antigen titers and less frequent lung involvement) and in terms of response to induction treatment (more CSF sterilization). Multivariate analysis showed that parameters independently associated with a lack of CSF sterilization at week 2 after initiation of treatment were a high serum antigen titer (Ͼ512), the lack of flucytosine during induction therapy (as reported before [5] ), and the occurrence of mixed infection, while infection with AD hybrids was more often associated with CSF sterilization. Nevertheless, differences in CSF sterilization do not prove differences in virulence in humans. We should keep in mind that the AD hybrids identified in patients diagnosed in France are different from those found in Africa, and indeed, Wiesner et al. found no survivors among the 8 Ugandan patients infected by AD hybrids (48) , whereas survival was similar whatever the infecting serotype for the patients enrolled in the CryptoA/D study. Virulence of AD hybrids has been assessed in experimental infections using relatively few strains (12, 32, 34) . The mating type, the inoculation route, and the presence of the A␣ allele have been associated with enhanced virulence. A recent study, however, demonstrated a significantly lower virulence only for the aADa hybrids, providing evidence for negative epistatic interactions between Aa and Da alleles (49) . This was not assessed here because of the small number of patients involved for some of the allele combinations. A higher DNA content does not explain differences in virulence for AD hybrids because genetically related haploid and diploid isolates exhibit similar virulence (36, 49) . However, diploid cells are thought to be larger than haploid cells, and cell size can have an impact on phagocytosis (described for titan cells [50] ). Chromosomal composition (proportion of serotype A or D genomes) in AD hybrids varies with partial and/or complete chromosome deletion and/or duplication (11, 12, 35) , with an impact on capsule structure, as shown here by the difference in serotype assignment achieved with a monoclonal antibody (51) . Our study again highlights the importance of combining clinical and molecular data on original isolates for the study of cryptococcosis and most probably other fungal infections. This approach could be essential to identify putative species-and cladespecific risk factors and possible associations between particular strain types and host microenvironment and could lead to optimized recommendations for the management of the patients. Cryptococcus neoformans isolates. Molecular characterization was performed for 400 isolates obtained from 380 original isolates recovered from 181 patients (CryptoA/D isolates) and for 53 serotype D isolates collected from 53 patients during the surveillance program implemented at the National Reference Center for Invasive Mycoses and antifungals (CNRMA) (52) . Reference strains JEC21 (serotype D, MAT␣), JEC20 (serotype D, MATa), H99 (serotype A, MAT␣), KN99a (serotype, A MATa), and KN99␣ (serotype A, MAT␣) were used. Molecular characterization. (i) Determination of ploidy. Cells were prepared for flow cytometry (53) . Data were acquired from 30,000 cells using the FL2 channel of a BD FACScan flow cytometer (Becton, Dickinson Company, Franklin Lakes, NJ, USA). Analysis was performed using CellQuest software version 3.3 (BD Biosciences, San Jose, CA, USA) using the profile of H99␣ as a reference for haploidy.
MATERIALS AND METHODS
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(ii) Determination of mating type and serotype. Yeasts were grown for 24 h at 28°C on solid YNB medium. DNA was extracted using the High-Pure PCR template preparation kit (Roche Applied Science, Indianapolis, IN). PCR were performed on an iCycler thermocycler (Bio-Rad, Hercules, CA) using primers specific for the serotype and the mating type (SXI1␣/SXI2a and STE20␣/a) (12) . Serotype-specific primers for the PAK1 and GPA1 genes were also used for all original cultures and selected single colonies (12) . For some isolates, other STE20 primers were used (Table 5 ) because of a deletion in the STE20 sequences.
(iii) MLST. Multilocus sequence typing (MLST) was performed on all serotype A and D isolates using the published scheme (CAP59, URA5, GPD1, SOD1, LAC1, IGS1, PLB1) (19) with slightly different conditions for serotype D (36) . Of note, LAC1 and URA5 loci are both localized on chromosomes 8 and 7 for serotypes A and D, respectively, whereas the other five loci are on different chromosomes. Sequences were edited with Chromas Pro version 1.41 (Technelysium Pty. Ltd., Helensvale, Queensland, Australia) and Mega version 5.1 (54) . Concatenate sequences of the 7 MLST loci were aligned to construct a similarity matrix using BioNumerics version 6.6 (Applied Maths, NV). The MLST allelic sequences and sequence type (ST) are available online (http://mlst.mycologylab.org/ defaultinfo.aspx?PageϭCN).
Discriminatory power was determined by using Hunter coefficient (55). Frequency of each ST was calculated by using START software version 2 and LIAN3.5 software (56) . Gene diversity (H) was calculated as [n/(n Ϫ 1)](1 Ϫ ⌺p 2 i ), where n is the number of samples and pi is the relative frequency of the ith allele. Average number of alleles per locus was determined as (1/k)⌺n i , where k is the total number of loci and n i is the number of alleles for one locus.
Genotypes for AD hybrid were determined for 5 loci (PLB1, GPD1, SOD1, IGS1, and LAC1) by using serotype-specific primers (11, 36) . We were not able to design serotype-specific primers for the CAP59 and URA5 loci due to high sequence similarity between A and D alleles.
Phylogenetic analysis. For the population genetics analysis, only one isolate per patient was used except when different genotypes were observed in a given patient. A total of 97 isolates from 97 patients was studied for serotype D and 121 isolates from 118 patients for serotype A. Minimum-spanning trees were constructed with MLST alleles using BioNumerics. Clusters were defined as partitions of nodes having a maximum distance of two loci. Isolates located in the same cluster were considered related. Maximum-parsimony trees were constructed using BioNumerics, with concatenate sequences of the 7 MLST loci aligned using ClustalW.
An allele compatibility test was performed from ST global isolates by generation of 21 graphs. This test calculates the proportion of loci that show phylogenetic compatibility when compared in pairwise combinations. In the simplest case of phylogenetic compatibility, for two loci with two alleles each, if all four possible genotypes are found in the population, these two loci are called phylogenetically incompatible. An hourglass shape thus indicates the presence of all four possible pairs of alleles and serves as evidence for recombination (57) . The index of congruence (I cong ) was calculated using online calculation (58) (http://mobyle.pasteur.fr/cgi-bin/portal.py#welcome) for testing topological similarity between haplotypes trees by comparing pairwise combination (here, 21 combinations for 7 MLST loci) and calculating the P value for each combination. Congruence between trees can suggest coevolution of genes, i.e., no recombination events.
The index of association (I A ) and linkage disequilibrium were determined by using START software version 2 and LIAN3.5 software (56) . I A is the ratio of the observed variance in the association of alleles among loci to the corresponding expected variance based on random associations. Significant associations among alleles at different loci are inconsistent with random recombination but consistent with clonality.
DnaSP software version 5.10 was used to calculate recombination parameters, with S representing the number of segregating sites, R the number of recombination events, and Rm the number of recombination events that can be parsimoniously inferred from the sequences (59) .
Statistical analysis. Correlations between clinical and molecular data were analyzed for the CryptoA/D patients (Stata 10.0; Stata Corporation, College Station, TX). Comparisons between groups were done using chi square or Fisher exact tests for categorical variables, and Student's t test or one-way analysis of variance for continuous variables. For the multivariate analysis, logistic regression was used to determine factors associated with mycological failure (lack of CSF sterilization) at week 2. Odds ratios (OR) and 95% confidence intervals (CI) were determined by means of logistic regression analysis. Variables that were clinically relevant with P values of 0.25 were entered simultaneously into the initial model. Variables were removed following a backward-stepwise selection procedure, leaving only variables with P values of 0.05 in the final model. We estimated overall survival (cumulative survival probabilities and their 95% CIs) by the Kaplan-Meier method, and comparison of survival between groups was performed by log rank tests.
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